nodes	percent_of_prediction	percent_of_DWPC	metapath
Tramadol—CYP2B6—Irinotecan—lung cancer	0.0464	0.104	CbGbCtD
Tramadol—CYP2D6—Gefitinib—lung cancer	0.042	0.094	CbGbCtD
Tramadol—CYP2B6—Cisplatin—lung cancer	0.0378	0.0847	CbGbCtD
Tramadol—CYP2D6—Vinorelbine—lung cancer	0.0323	0.0724	CbGbCtD
Tramadol—CYP3A4—Topotecan—lung cancer	0.0292	0.0654	CbGbCtD
Tramadol—CYP3A4—Gefitinib—lung cancer	0.0267	0.0598	CbGbCtD
Tramadol—CYP3A4—Teniposide—lung cancer	0.0259	0.058	CbGbCtD
Tramadol—CYP2B6—Doxorubicin—lung cancer	0.0253	0.0568	CbGbCtD
Tramadol—CYP2D6—Erlotinib—lung cancer	0.0248	0.0556	CbGbCtD
Tramadol—CYP3A4—Vinorelbine—lung cancer	0.0205	0.0461	CbGbCtD
Tramadol—CYP2D6—Vinblastine—lung cancer	0.0199	0.0446	CbGbCtD
Tramadol—CYP3A4—Crizotinib—lung cancer	0.0164	0.0367	CbGbCtD
Tramadol—CYP3A4—Erlotinib—lung cancer	0.0158	0.0354	CbGbCtD
Tramadol—CYP3A4—Paclitaxel—lung cancer	0.0144	0.0324	CbGbCtD
Tramadol—CYP3A4—Irinotecan—lung cancer	0.0142	0.0319	CbGbCtD
Tramadol—CYP3A4—Vinblastine—lung cancer	0.0127	0.0284	CbGbCtD
Tramadol—CYP2D6—Doxorubicin—lung cancer	0.0122	0.0274	CbGbCtD
Tramadol—CYP3A4—Etoposide—lung cancer	0.0114	0.0256	CbGbCtD
Tramadol—CYP3A4—Docetaxel—lung cancer	0.0104	0.0234	CbGbCtD
Tramadol—CYP3A4—Doxorubicin—lung cancer	0.00778	0.0174	CbGbCtD
Tramadol—Dextromethorphan—CHRNB4—lung cancer	0.00334	0.35	CrCbGaD
Tramadol—Dextromethorphan—CHRNA3—lung cancer	0.00231	0.243	CrCbGaD
Tramadol—Venlafaxine—ABCG2—lung cancer	0.002	0.209	CrCbGaD
Tramadol—Venlafaxine—ABCB1—lung cancer	0.000831	0.0871	CrCbGaD
Tramadol—Dextromethorphan—CYP2E1—lung cancer	0.000694	0.0728	CrCbGaD
Tramadol—Dextromethorphan—ABCB1—lung cancer	0.000364	0.0382	CrCbGaD
Tramadol—Urinary tract disorder—Methotrexate—lung cancer	8.46e-05	0.000204	CcSEcCtD
Tramadol—Photosensitivity reaction—Doxorubicin—lung cancer	8.46e-05	0.000204	CcSEcCtD
Tramadol—Anaphylactic shock—Docetaxel—lung cancer	8.45e-05	0.000203	CcSEcCtD
Tramadol—Pruritus—Gemcitabine—lung cancer	8.42e-05	0.000203	CcSEcCtD
Tramadol—Urethral disorder—Methotrexate—lung cancer	8.4e-05	0.000202	CcSEcCtD
Tramadol—Infection—Docetaxel—lung cancer	8.39e-05	0.000202	CcSEcCtD
Tramadol—Weight decreased—Doxorubicin—lung cancer	8.39e-05	0.000202	CcSEcCtD
Tramadol—Feeling abnormal—Etoposide—lung cancer	8.38e-05	0.000202	CcSEcCtD
Tramadol—Hyperglycaemia—Doxorubicin—lung cancer	8.36e-05	0.000201	CcSEcCtD
Tramadol—Diarrhoea—Irinotecan—lung cancer	8.36e-05	0.000201	CcSEcCtD
Tramadol—Pneumonia—Doxorubicin—lung cancer	8.31e-05	0.0002	CcSEcCtD
Tramadol—Gastrointestinal pain—Etoposide—lung cancer	8.31e-05	0.0002	CcSEcCtD
Tramadol—Shock—Docetaxel—lung cancer	8.31e-05	0.0002	CcSEcCtD
Tramadol—Nervous system disorder—Docetaxel—lung cancer	8.28e-05	0.000199	CcSEcCtD
Tramadol—Thrombocytopenia—Docetaxel—lung cancer	8.27e-05	0.000199	CcSEcCtD
Tramadol—Infestation—Doxorubicin—lung cancer	8.27e-05	0.000199	CcSEcCtD
Tramadol—Infestation NOS—Doxorubicin—lung cancer	8.27e-05	0.000199	CcSEcCtD
Tramadol—Visual impairment—Methotrexate—lung cancer	8.26e-05	0.000199	CcSEcCtD
Tramadol—Tachycardia—Docetaxel—lung cancer	8.24e-05	0.000198	CcSEcCtD
Tramadol—Feeling abnormal—Paclitaxel—lung cancer	8.21e-05	0.000198	CcSEcCtD
Tramadol—Skin disorder—Docetaxel—lung cancer	8.2e-05	0.000197	CcSEcCtD
Tramadol—Stevens-Johnson syndrome—Doxorubicin—lung cancer	8.19e-05	0.000197	CcSEcCtD
Tramadol—Hypersensitivity—Cisplatin—lung cancer	8.17e-05	0.000197	CcSEcCtD
Tramadol—Gastrointestinal pain—Paclitaxel—lung cancer	8.15e-05	0.000196	CcSEcCtD
Tramadol—Diarrhoea—Gemcitabine—lung cancer	8.14e-05	0.000196	CcSEcCtD
Tramadol—Renal failure—Doxorubicin—lung cancer	8.12e-05	0.000196	CcSEcCtD
Tramadol—Erythema multiforme—Methotrexate—lung cancer	8.1e-05	0.000195	CcSEcCtD
Tramadol—Dizziness—Irinotecan—lung cancer	8.08e-05	0.000194	CcSEcCtD
Tramadol—Urticaria—Etoposide—lung cancer	8.07e-05	0.000194	CcSEcCtD
Tramadol—Stomatitis—Doxorubicin—lung cancer	8.06e-05	0.000194	CcSEcCtD
Tramadol—Anorexia—Docetaxel—lung cancer	8.05e-05	0.000194	CcSEcCtD
Tramadol—Abdominal pain—Etoposide—lung cancer	8.03e-05	0.000193	CcSEcCtD
Tramadol—Body temperature increased—Etoposide—lung cancer	8.03e-05	0.000193	CcSEcCtD
Tramadol—Urinary tract infection—Doxorubicin—lung cancer	8.03e-05	0.000193	CcSEcCtD
Tramadol—Conjunctivitis—Doxorubicin—lung cancer	8.03e-05	0.000193	CcSEcCtD
Tramadol—Eye disorder—Methotrexate—lung cancer	8.01e-05	0.000193	CcSEcCtD
Tramadol—Tinnitus—Methotrexate—lung cancer	7.99e-05	0.000192	CcSEcCtD
Tramadol—Asthenia—Cisplatin—lung cancer	7.96e-05	0.000192	CcSEcCtD
Tramadol—Cardiac disorder—Methotrexate—lung cancer	7.95e-05	0.000191	CcSEcCtD
Tramadol—Sweating—Doxorubicin—lung cancer	7.92e-05	0.000191	CcSEcCtD
Tramadol—Urticaria—Paclitaxel—lung cancer	7.92e-05	0.000191	CcSEcCtD
Tramadol—Hypotension—Docetaxel—lung cancer	7.89e-05	0.00019	CcSEcCtD
Tramadol—Haematuria—Doxorubicin—lung cancer	7.88e-05	0.00019	CcSEcCtD
Tramadol—Abdominal pain—Paclitaxel—lung cancer	7.88e-05	0.00019	CcSEcCtD
Tramadol—Body temperature increased—Paclitaxel—lung cancer	7.88e-05	0.00019	CcSEcCtD
Tramadol—Hepatobiliary disease—Doxorubicin—lung cancer	7.82e-05	0.000188	CcSEcCtD
Tramadol—Epistaxis—Doxorubicin—lung cancer	7.8e-05	0.000188	CcSEcCtD
Tramadol—Angiopathy—Methotrexate—lung cancer	7.77e-05	0.000187	CcSEcCtD
Tramadol—Vomiting—Irinotecan—lung cancer	7.77e-05	0.000187	CcSEcCtD
Tramadol—Sinusitis—Doxorubicin—lung cancer	7.75e-05	0.000187	CcSEcCtD
Tramadol—Immune system disorder—Methotrexate—lung cancer	7.74e-05	0.000186	CcSEcCtD
Tramadol—Mediastinal disorder—Methotrexate—lung cancer	7.72e-05	0.000186	CcSEcCtD
Tramadol—Rash—Irinotecan—lung cancer	7.7e-05	0.000185	CcSEcCtD
Tramadol—Dermatitis—Irinotecan—lung cancer	7.7e-05	0.000185	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Docetaxel—lung cancer	7.7e-05	0.000185	CcSEcCtD
Tramadol—Chills—Methotrexate—lung cancer	7.69e-05	0.000185	CcSEcCtD
Tramadol—Headache—Irinotecan—lung cancer	7.65e-05	0.000184	CcSEcCtD
Tramadol—Insomnia—Docetaxel—lung cancer	7.64e-05	0.000184	CcSEcCtD
Tramadol—Diarrhoea—Cisplatin—lung cancer	7.59e-05	0.000183	CcSEcCtD
Tramadol—Paraesthesia—Docetaxel—lung cancer	7.58e-05	0.000183	CcSEcCtD
Tramadol—Vomiting—Gemcitabine—lung cancer	7.57e-05	0.000182	CcSEcCtD
Tramadol—Bradycardia—Doxorubicin—lung cancer	7.55e-05	0.000182	CcSEcCtD
Tramadol—Dyspnoea—Docetaxel—lung cancer	7.53e-05	0.000181	CcSEcCtD
Tramadol—Somnolence—Docetaxel—lung cancer	7.51e-05	0.000181	CcSEcCtD
Tramadol—Mental disorder—Methotrexate—lung cancer	7.51e-05	0.000181	CcSEcCtD
Tramadol—Rash—Gemcitabine—lung cancer	7.5e-05	0.000181	CcSEcCtD
Tramadol—Dermatitis—Gemcitabine—lung cancer	7.5e-05	0.00018	CcSEcCtD
Tramadol—Hypersensitivity—Etoposide—lung cancer	7.49e-05	0.00018	CcSEcCtD
Tramadol—Malnutrition—Methotrexate—lung cancer	7.46e-05	0.00018	CcSEcCtD
Tramadol—Erythema—Methotrexate—lung cancer	7.46e-05	0.00018	CcSEcCtD
Tramadol—Haemoglobin—Doxorubicin—lung cancer	7.46e-05	0.00018	CcSEcCtD
Tramadol—Headache—Gemcitabine—lung cancer	7.46e-05	0.000179	CcSEcCtD
Tramadol—Rhinitis—Doxorubicin—lung cancer	7.44e-05	0.000179	CcSEcCtD
Tramadol—Dyspepsia—Docetaxel—lung cancer	7.43e-05	0.000179	CcSEcCtD
Tramadol—Haemorrhage—Doxorubicin—lung cancer	7.42e-05	0.000179	CcSEcCtD
Tramadol—Hepatitis—Doxorubicin—lung cancer	7.42e-05	0.000179	CcSEcCtD
Tramadol—Hypoaesthesia—Doxorubicin—lung cancer	7.38e-05	0.000178	CcSEcCtD
Tramadol—Pharyngitis—Doxorubicin—lung cancer	7.36e-05	0.000177	CcSEcCtD
Tramadol—Decreased appetite—Docetaxel—lung cancer	7.34e-05	0.000177	CcSEcCtD
Tramadol—Hypersensitivity—Paclitaxel—lung cancer	7.34e-05	0.000177	CcSEcCtD
Tramadol—Urinary tract disorder—Doxorubicin—lung cancer	7.33e-05	0.000176	CcSEcCtD
Tramadol—Oedema peripheral—Doxorubicin—lung cancer	7.31e-05	0.000176	CcSEcCtD
Tramadol—Dysgeusia—Methotrexate—lung cancer	7.3e-05	0.000176	CcSEcCtD
Tramadol—Gastrointestinal disorder—Docetaxel—lung cancer	7.29e-05	0.000176	CcSEcCtD
Tramadol—Asthenia—Etoposide—lung cancer	7.29e-05	0.000176	CcSEcCtD
Tramadol—Connective tissue disorder—Doxorubicin—lung cancer	7.29e-05	0.000176	CcSEcCtD
Tramadol—Fatigue—Docetaxel—lung cancer	7.28e-05	0.000175	CcSEcCtD
Tramadol—Urethral disorder—Doxorubicin—lung cancer	7.27e-05	0.000175	CcSEcCtD
Tramadol—Nausea—Irinotecan—lung cancer	7.26e-05	0.000175	CcSEcCtD
Tramadol—Constipation—Docetaxel—lung cancer	7.22e-05	0.000174	CcSEcCtD
Tramadol—Pain—Docetaxel—lung cancer	7.22e-05	0.000174	CcSEcCtD
Tramadol—Back pain—Methotrexate—lung cancer	7.22e-05	0.000174	CcSEcCtD
Tramadol—Pruritus—Etoposide—lung cancer	7.19e-05	0.000173	CcSEcCtD
Tramadol—Visual impairment—Doxorubicin—lung cancer	7.15e-05	0.000172	CcSEcCtD
Tramadol—Asthenia—Paclitaxel—lung cancer	7.15e-05	0.000172	CcSEcCtD
Tramadol—Nausea—Gemcitabine—lung cancer	7.07e-05	0.00017	CcSEcCtD
Tramadol—Vomiting—Cisplatin—lung cancer	7.05e-05	0.00017	CcSEcCtD
Tramadol—Pruritus—Paclitaxel—lung cancer	7.05e-05	0.00017	CcSEcCtD
Tramadol—Vision blurred—Methotrexate—lung cancer	7.03e-05	0.000169	CcSEcCtD
Tramadol—Erythema multiforme—Doxorubicin—lung cancer	7.02e-05	0.000169	CcSEcCtD
Tramadol—Rash—Cisplatin—lung cancer	6.99e-05	0.000168	CcSEcCtD
Tramadol—Dermatitis—Cisplatin—lung cancer	6.99e-05	0.000168	CcSEcCtD
Tramadol—Feeling abnormal—Docetaxel—lung cancer	6.96e-05	0.000168	CcSEcCtD
Tramadol—Diarrhoea—Etoposide—lung cancer	6.95e-05	0.000167	CcSEcCtD
Tramadol—Eye disorder—Doxorubicin—lung cancer	6.93e-05	0.000167	CcSEcCtD
Tramadol—Ill-defined disorder—Methotrexate—lung cancer	6.92e-05	0.000167	CcSEcCtD
Tramadol—Tinnitus—Doxorubicin—lung cancer	6.92e-05	0.000167	CcSEcCtD
Tramadol—Gastrointestinal pain—Docetaxel—lung cancer	6.91e-05	0.000166	CcSEcCtD
Tramadol—Anaemia—Methotrexate—lung cancer	6.89e-05	0.000166	CcSEcCtD
Tramadol—Cardiac disorder—Doxorubicin—lung cancer	6.89e-05	0.000166	CcSEcCtD
Tramadol—Flushing—Doxorubicin—lung cancer	6.89e-05	0.000166	CcSEcCtD
Tramadol—Diarrhoea—Paclitaxel—lung cancer	6.82e-05	0.000164	CcSEcCtD
Tramadol—Angiopathy—Doxorubicin—lung cancer	6.73e-05	0.000162	CcSEcCtD
Tramadol—Malaise—Methotrexate—lung cancer	6.73e-05	0.000162	CcSEcCtD
Tramadol—Dizziness—Etoposide—lung cancer	6.72e-05	0.000162	CcSEcCtD
Tramadol—Immune system disorder—Doxorubicin—lung cancer	6.7e-05	0.000161	CcSEcCtD
Tramadol—Vertigo—Methotrexate—lung cancer	6.7e-05	0.000161	CcSEcCtD
Tramadol—Mediastinal disorder—Doxorubicin—lung cancer	6.69e-05	0.000161	CcSEcCtD
Tramadol—Abdominal pain—Docetaxel—lung cancer	6.68e-05	0.000161	CcSEcCtD
Tramadol—Body temperature increased—Docetaxel—lung cancer	6.68e-05	0.000161	CcSEcCtD
Tramadol—Chills—Doxorubicin—lung cancer	6.66e-05	0.00016	CcSEcCtD
Tramadol—Arrhythmia—Doxorubicin—lung cancer	6.63e-05	0.00016	CcSEcCtD
Tramadol—Dizziness—Paclitaxel—lung cancer	6.59e-05	0.000159	CcSEcCtD
Tramadol—Nausea—Cisplatin—lung cancer	6.59e-05	0.000159	CcSEcCtD
Tramadol—Cough—Methotrexate—lung cancer	6.51e-05	0.000157	CcSEcCtD
Tramadol—Mental disorder—Doxorubicin—lung cancer	6.5e-05	0.000156	CcSEcCtD
Tramadol—Convulsion—Methotrexate—lung cancer	6.46e-05	0.000156	CcSEcCtD
Tramadol—Vomiting—Etoposide—lung cancer	6.46e-05	0.000156	CcSEcCtD
Tramadol—Malnutrition—Doxorubicin—lung cancer	6.46e-05	0.000155	CcSEcCtD
Tramadol—Erythema—Doxorubicin—lung cancer	6.46e-05	0.000155	CcSEcCtD
Tramadol—Rash—Etoposide—lung cancer	6.41e-05	0.000154	CcSEcCtD
Tramadol—Dermatitis—Etoposide—lung cancer	6.4e-05	0.000154	CcSEcCtD
Tramadol—Headache—Etoposide—lung cancer	6.37e-05	0.000153	CcSEcCtD
Tramadol—Flatulence—Doxorubicin—lung cancer	6.36e-05	0.000153	CcSEcCtD
Tramadol—Chest pain—Methotrexate—lung cancer	6.35e-05	0.000153	CcSEcCtD
Tramadol—Myalgia—Methotrexate—lung cancer	6.35e-05	0.000153	CcSEcCtD
Tramadol—Arthralgia—Methotrexate—lung cancer	6.35e-05	0.000153	CcSEcCtD
Tramadol—Tension—Doxorubicin—lung cancer	6.34e-05	0.000153	CcSEcCtD
Tramadol—Vomiting—Paclitaxel—lung cancer	6.34e-05	0.000153	CcSEcCtD
Tramadol—Dysgeusia—Doxorubicin—lung cancer	6.33e-05	0.000152	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	6.31e-05	0.000152	CcSEcCtD
Tramadol—Rash—Paclitaxel—lung cancer	6.28e-05	0.000151	CcSEcCtD
Tramadol—Dermatitis—Paclitaxel—lung cancer	6.28e-05	0.000151	CcSEcCtD
Tramadol—Discomfort—Methotrexate—lung cancer	6.27e-05	0.000151	CcSEcCtD
Tramadol—Nervousness—Doxorubicin—lung cancer	6.27e-05	0.000151	CcSEcCtD
Tramadol—Back pain—Doxorubicin—lung cancer	6.25e-05	0.00015	CcSEcCtD
Tramadol—Headache—Paclitaxel—lung cancer	6.24e-05	0.00015	CcSEcCtD
Tramadol—Hypersensitivity—Docetaxel—lung cancer	6.22e-05	0.00015	CcSEcCtD
Tramadol—Muscle spasms—Doxorubicin—lung cancer	6.21e-05	0.000149	CcSEcCtD
Tramadol—Confusional state—Methotrexate—lung cancer	6.14e-05	0.000148	CcSEcCtD
Tramadol—Anaphylactic shock—Methotrexate—lung cancer	6.09e-05	0.000147	CcSEcCtD
Tramadol—Vision blurred—Doxorubicin—lung cancer	6.09e-05	0.000147	CcSEcCtD
Tramadol—Asthenia—Docetaxel—lung cancer	6.06e-05	0.000146	CcSEcCtD
Tramadol—Infection—Methotrexate—lung cancer	6.05e-05	0.000146	CcSEcCtD
Tramadol—Nausea—Etoposide—lung cancer	6.04e-05	0.000145	CcSEcCtD
Tramadol—Ill-defined disorder—Doxorubicin—lung cancer	5.99e-05	0.000144	CcSEcCtD
Tramadol—Pruritus—Docetaxel—lung cancer	5.98e-05	0.000144	CcSEcCtD
Tramadol—Nervous system disorder—Methotrexate—lung cancer	5.97e-05	0.000144	CcSEcCtD
Tramadol—Anaemia—Doxorubicin—lung cancer	5.97e-05	0.000144	CcSEcCtD
Tramadol—Thrombocytopenia—Methotrexate—lung cancer	5.96e-05	0.000143	CcSEcCtD
Tramadol—Agitation—Doxorubicin—lung cancer	5.94e-05	0.000143	CcSEcCtD
Tramadol—Nausea—Paclitaxel—lung cancer	5.92e-05	0.000142	CcSEcCtD
Tramadol—Skin disorder—Methotrexate—lung cancer	5.91e-05	0.000142	CcSEcCtD
Tramadol—Hyperhidrosis—Methotrexate—lung cancer	5.89e-05	0.000142	CcSEcCtD
Tramadol—Malaise—Doxorubicin—lung cancer	5.82e-05	0.00014	CcSEcCtD
Tramadol—Vertigo—Doxorubicin—lung cancer	5.8e-05	0.00014	CcSEcCtD
Tramadol—Anorexia—Methotrexate—lung cancer	5.8e-05	0.00014	CcSEcCtD
Tramadol—Syncope—Doxorubicin—lung cancer	5.79e-05	0.000139	CcSEcCtD
Tramadol—Diarrhoea—Docetaxel—lung cancer	5.78e-05	0.000139	CcSEcCtD
Tramadol—Palpitations—Doxorubicin—lung cancer	5.71e-05	0.000137	CcSEcCtD
Tramadol—Hypotension—Methotrexate—lung cancer	5.69e-05	0.000137	CcSEcCtD
Tramadol—Loss of consciousness—Doxorubicin—lung cancer	5.68e-05	0.000137	CcSEcCtD
Tramadol—Cough—Doxorubicin—lung cancer	5.64e-05	0.000136	CcSEcCtD
Tramadol—Convulsion—Doxorubicin—lung cancer	5.6e-05	0.000135	CcSEcCtD
Tramadol—Dizziness—Docetaxel—lung cancer	5.59e-05	0.000134	CcSEcCtD
Tramadol—Hypertension—Doxorubicin—lung cancer	5.58e-05	0.000134	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Methotrexate—lung cancer	5.55e-05	0.000134	CcSEcCtD
Tramadol—Insomnia—Methotrexate—lung cancer	5.51e-05	0.000133	CcSEcCtD
Tramadol—Chest pain—Doxorubicin—lung cancer	5.5e-05	0.000132	CcSEcCtD
Tramadol—Arthralgia—Doxorubicin—lung cancer	5.5e-05	0.000132	CcSEcCtD
Tramadol—Myalgia—Doxorubicin—lung cancer	5.5e-05	0.000132	CcSEcCtD
Tramadol—Anxiety—Doxorubicin—lung cancer	5.48e-05	0.000132	CcSEcCtD
Tramadol—Paraesthesia—Methotrexate—lung cancer	5.47e-05	0.000132	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	5.46e-05	0.000131	CcSEcCtD
Tramadol—Discomfort—Doxorubicin—lung cancer	5.43e-05	0.000131	CcSEcCtD
Tramadol—Dyspnoea—Methotrexate—lung cancer	5.43e-05	0.000131	CcSEcCtD
Tramadol—Somnolence—Methotrexate—lung cancer	5.41e-05	0.00013	CcSEcCtD
Tramadol—Dry mouth—Doxorubicin—lung cancer	5.38e-05	0.000129	CcSEcCtD
Tramadol—Vomiting—Docetaxel—lung cancer	5.37e-05	0.000129	CcSEcCtD
Tramadol—Dyspepsia—Methotrexate—lung cancer	5.36e-05	0.000129	CcSEcCtD
Tramadol—Rash—Docetaxel—lung cancer	5.33e-05	0.000128	CcSEcCtD
Tramadol—Dermatitis—Docetaxel—lung cancer	5.32e-05	0.000128	CcSEcCtD
Tramadol—Confusional state—Doxorubicin—lung cancer	5.32e-05	0.000128	CcSEcCtD
Tramadol—Decreased appetite—Methotrexate—lung cancer	5.29e-05	0.000127	CcSEcCtD
Tramadol—Headache—Docetaxel—lung cancer	5.29e-05	0.000127	CcSEcCtD
Tramadol—Anaphylactic shock—Doxorubicin—lung cancer	5.27e-05	0.000127	CcSEcCtD
Tramadol—Gastrointestinal disorder—Methotrexate—lung cancer	5.26e-05	0.000127	CcSEcCtD
Tramadol—Fatigue—Methotrexate—lung cancer	5.25e-05	0.000126	CcSEcCtD
Tramadol—Infection—Doxorubicin—lung cancer	5.24e-05	0.000126	CcSEcCtD
Tramadol—Pain—Methotrexate—lung cancer	5.21e-05	0.000125	CcSEcCtD
Tramadol—Shock—Doxorubicin—lung cancer	5.19e-05	0.000125	CcSEcCtD
Tramadol—Nervous system disorder—Doxorubicin—lung cancer	5.17e-05	0.000124	CcSEcCtD
Tramadol—Thrombocytopenia—Doxorubicin—lung cancer	5.16e-05	0.000124	CcSEcCtD
Tramadol—Tachycardia—Doxorubicin—lung cancer	5.14e-05	0.000124	CcSEcCtD
Tramadol—Skin disorder—Doxorubicin—lung cancer	5.12e-05	0.000123	CcSEcCtD
Tramadol—Hyperhidrosis—Doxorubicin—lung cancer	5.1e-05	0.000123	CcSEcCtD
Tramadol—Anorexia—Doxorubicin—lung cancer	5.02e-05	0.000121	CcSEcCtD
Tramadol—Nausea—Docetaxel—lung cancer	5.02e-05	0.000121	CcSEcCtD
Tramadol—Feeling abnormal—Methotrexate—lung cancer	5.02e-05	0.000121	CcSEcCtD
Tramadol—Gastrointestinal pain—Methotrexate—lung cancer	4.98e-05	0.00012	CcSEcCtD
Tramadol—Hypotension—Doxorubicin—lung cancer	4.93e-05	0.000119	CcSEcCtD
Tramadol—Urticaria—Methotrexate—lung cancer	4.84e-05	0.000116	CcSEcCtD
Tramadol—Abdominal pain—Methotrexate—lung cancer	4.81e-05	0.000116	CcSEcCtD
Tramadol—Body temperature increased—Methotrexate—lung cancer	4.81e-05	0.000116	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Doxorubicin—lung cancer	4.8e-05	0.000116	CcSEcCtD
Tramadol—Insomnia—Doxorubicin—lung cancer	4.77e-05	0.000115	CcSEcCtD
Tramadol—Paraesthesia—Doxorubicin—lung cancer	4.73e-05	0.000114	CcSEcCtD
Tramadol—Dyspnoea—Doxorubicin—lung cancer	4.7e-05	0.000113	CcSEcCtD
Tramadol—Somnolence—Doxorubicin—lung cancer	4.69e-05	0.000113	CcSEcCtD
Tramadol—Dyspepsia—Doxorubicin—lung cancer	4.64e-05	0.000112	CcSEcCtD
Tramadol—Decreased appetite—Doxorubicin—lung cancer	4.58e-05	0.00011	CcSEcCtD
Tramadol—Gastrointestinal disorder—Doxorubicin—lung cancer	4.55e-05	0.00011	CcSEcCtD
Tramadol—Fatigue—Doxorubicin—lung cancer	4.54e-05	0.000109	CcSEcCtD
Tramadol—Pain—Doxorubicin—lung cancer	4.51e-05	0.000109	CcSEcCtD
Tramadol—Constipation—Doxorubicin—lung cancer	4.51e-05	0.000109	CcSEcCtD
Tramadol—Hypersensitivity—Methotrexate—lung cancer	4.49e-05	0.000108	CcSEcCtD
Tramadol—Asthenia—Methotrexate—lung cancer	4.37e-05	0.000105	CcSEcCtD
Tramadol—Feeling abnormal—Doxorubicin—lung cancer	4.34e-05	0.000105	CcSEcCtD
Tramadol—Gastrointestinal pain—Doxorubicin—lung cancer	4.31e-05	0.000104	CcSEcCtD
Tramadol—Pruritus—Methotrexate—lung cancer	4.31e-05	0.000104	CcSEcCtD
Tramadol—Urticaria—Doxorubicin—lung cancer	4.19e-05	0.000101	CcSEcCtD
Tramadol—Abdominal pain—Doxorubicin—lung cancer	4.17e-05	0.0001	CcSEcCtD
Tramadol—Body temperature increased—Doxorubicin—lung cancer	4.17e-05	0.0001	CcSEcCtD
Tramadol—Diarrhoea—Methotrexate—lung cancer	4.17e-05	0.0001	CcSEcCtD
Tramadol—Dizziness—Methotrexate—lung cancer	4.03e-05	9.69e-05	CcSEcCtD
Tramadol—Hypersensitivity—Doxorubicin—lung cancer	3.88e-05	9.35e-05	CcSEcCtD
Tramadol—Vomiting—Methotrexate—lung cancer	3.87e-05	9.32e-05	CcSEcCtD
Tramadol—Rash—Methotrexate—lung cancer	3.84e-05	9.24e-05	CcSEcCtD
Tramadol—Dermatitis—Methotrexate—lung cancer	3.83e-05	9.23e-05	CcSEcCtD
Tramadol—Headache—Methotrexate—lung cancer	3.81e-05	9.18e-05	CcSEcCtD
Tramadol—Asthenia—Doxorubicin—lung cancer	3.78e-05	9.1e-05	CcSEcCtD
Tramadol—Pruritus—Doxorubicin—lung cancer	3.73e-05	8.98e-05	CcSEcCtD
Tramadol—Nausea—Methotrexate—lung cancer	3.62e-05	8.7e-05	CcSEcCtD
Tramadol—Diarrhoea—Doxorubicin—lung cancer	3.61e-05	8.68e-05	CcSEcCtD
Tramadol—Dizziness—Doxorubicin—lung cancer	3.49e-05	8.39e-05	CcSEcCtD
Tramadol—Vomiting—Doxorubicin—lung cancer	3.35e-05	8.07e-05	CcSEcCtD
Tramadol—Rash—Doxorubicin—lung cancer	3.32e-05	8e-05	CcSEcCtD
Tramadol—Dermatitis—Doxorubicin—lung cancer	3.32e-05	7.99e-05	CcSEcCtD
Tramadol—Headache—Doxorubicin—lung cancer	3.3e-05	7.95e-05	CcSEcCtD
Tramadol—Nausea—Doxorubicin—lung cancer	3.13e-05	7.54e-05	CcSEcCtD
Tramadol—CHRM3—Signaling Pathways—TERT—lung cancer	1.16e-05	9.03e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—AKT1—lung cancer	1.16e-05	8.97e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CXCL8—lung cancer	1.16e-05	8.96e-05	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—PIK3CA—lung cancer	1.16e-05	8.96e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—HRAS—lung cancer	1.15e-05	8.91e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—KRAS—lung cancer	1.14e-05	8.86e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—APC—lung cancer	1.14e-05	8.84e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—KIT—lung cancer	1.14e-05	8.84e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PIK3CG—lung cancer	1.14e-05	8.84e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—NRAS—lung cancer	1.14e-05	8.84e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GNG11—lung cancer	1.13e-05	8.79e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—FGFR1—lung cancer	1.13e-05	8.77e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—EP300—lung cancer	1.13e-05	8.77e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—EGF—lung cancer	1.13e-05	8.73e-05	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—AKT1—lung cancer	1.12e-05	8.66e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—POMC—lung cancer	1.12e-05	8.66e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—HIF1A—lung cancer	1.11e-05	8.64e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—STK11—lung cancer	1.11e-05	8.62e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CASP3—lung cancer	1.11e-05	8.58e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—APOA1—lung cancer	1.11e-05	8.57e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—IL2—lung cancer	1.1e-05	8.57e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—SRC—lung cancer	1.1e-05	8.53e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—IL6—lung cancer	1.1e-05	8.52e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—MAPK3—lung cancer	1.09e-05	8.46e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—CREBBP—lung cancer	1.09e-05	8.44e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—POMC—lung cancer	1.08e-05	8.41e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ALDOA—lung cancer	1.08e-05	8.37e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CCND1—lung cancer	1.08e-05	8.35e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—JUN—lung cancer	1.07e-05	8.33e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—APOA1—lung cancer	1.07e-05	8.33e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—BRAF—lung cancer	1.07e-05	8.31e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—VEGFA—lung cancer	1.07e-05	8.3e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—KDR—lung cancer	1.06e-05	8.26e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—STAT3—lung cancer	1.06e-05	8.22e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IL6R—lung cancer	1.06e-05	8.2e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—NRAS—lung cancer	1.06e-05	8.2e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CREBBP—lung cancer	1.06e-05	8.19e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—PIK3CA—lung cancer	1.05e-05	8.14e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—NCOA3—lung cancer	1.05e-05	8.13e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—MMP9—lung cancer	1.05e-05	8.11e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MDM2—lung cancer	1.04e-05	8.1e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CDKN1A—lung cancer	1.04e-05	8.08e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—RAF1—lung cancer	1.04e-05	8.08e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—PTEN—lung cancer	1.04e-05	8.06e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—EGFR—lung cancer	1.04e-05	8.05e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PIK3CD—lung cancer	1.03e-05	8e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—ERBB2—lung cancer	1.03e-05	7.99e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—GSTP1—lung cancer	1.03e-05	7.97e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ADCY1—lung cancer	1.02e-05	7.91e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ABCG2—lung cancer	1.02e-05	7.91e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—ALB—lung cancer	1.02e-05	7.9e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PIK3CB—lung cancer	1.02e-05	7.88e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MTOR—lung cancer	1.02e-05	7.88e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—AKT1—lung cancer	1.01e-05	7.86e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—MAPK3—lung cancer	1.01e-05	7.86e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PIK3CG—lung cancer	1.01e-05	7.83e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MAP2K1—lung cancer	1.01e-05	7.82e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PIK3CD—lung cancer	1e-05	7.77e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CAT—lung cancer	1e-05	7.76e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—HPGDS—lung cancer	9.99e-06	7.75e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ENO2—lung cancer	9.99e-06	7.75e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PPP2R1B—lung cancer	9.93e-06	7.7e-05	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—PIK3CA—lung cancer	9.92e-06	7.69e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—EP300—lung cancer	9.91e-06	7.69e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—MYC—lung cancer	9.85e-06	7.64e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—KIT—lung cancer	9.81e-06	7.61e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PIK3CG—lung cancer	9.81e-06	7.61e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—APC—lung cancer	9.81e-06	7.61e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—NRAS—lung cancer	9.81e-06	7.61e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—KRAS—lung cancer	9.8e-06	7.6e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CXCL8—lung cancer	9.77e-06	7.58e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—ABCB1—lung cancer	9.73e-06	7.55e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—HRAS—lung cancer	9.7e-06	7.53e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GSTT1—lung cancer	9.69e-06	7.52e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—EGF—lung cancer	9.69e-06	7.52e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—SRC—lung cancer	9.64e-06	7.48e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—EGFR—lung cancer	9.63e-06	7.47e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—POMC—lung cancer	9.6e-06	7.45e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CYP2A6—lung cancer	9.58e-06	7.43e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GCLC—lung cancer	9.58e-06	7.43e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—TYMS—lung cancer	9.55e-06	7.41e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—GSTM1—lung cancer	9.44e-06	7.33e-05	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—AKT1—lung cancer	9.44e-06	7.32e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—MAPK3—lung cancer	9.39e-06	7.29e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—VEGFA—lung cancer	9.39e-06	7.28e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—CREBBP—lung cancer	9.35e-06	7.26e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CASP3—lung cancer	9.35e-06	7.25e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—POMC—lung cancer	9.34e-06	7.24e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—IL2—lung cancer	9.33e-06	7.24e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—STAT3—lung cancer	9.29e-06	7.21e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—IL6—lung cancer	9.29e-06	7.2e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—NRAS—lung cancer	9.27e-06	7.19e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—BRAF—lung cancer	9.22e-06	7.15e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IL6R—lung cancer	9.11e-06	7.06e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—KRAS—lung cancer	9.1e-06	7.06e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CCND1—lung cancer	9.1e-06	7.06e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CREBBP—lung cancer	9.09e-06	7.05e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ENO1—lung cancer	9.08e-06	7.05e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—JUN—lung cancer	9.08e-06	7.04e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—PIK3CA—lung cancer	9.01e-06	6.99e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PIK3CB—lung cancer	8.99e-06	6.97e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MDM2—lung cancer	8.97e-06	6.96e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CYP1A1—lung cancer	8.95e-06	6.95e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—RAF1—lung cancer	8.94e-06	6.93e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—EGFR—lung cancer	8.93e-06	6.93e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PTGS2—lung cancer	8.9e-06	6.91e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—ERCC2—lung cancer	8.88e-06	6.89e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—MAPK3—lung cancer	8.88e-06	6.89e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PIK3CD—lung cancer	8.87e-06	6.88e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—ERBB2—lung cancer	8.84e-06	6.86e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MMP9—lung cancer	8.83e-06	6.85e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CDKN1A—lung cancer	8.8e-06	6.83e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PTEN—lung cancer	8.78e-06	6.81e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—ALB—lung cancer	8.76e-06	6.79e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PIK3CB—lung cancer	8.73e-06	6.77e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MTOR—lung cancer	8.73e-06	6.77e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MAP2K1—lung cancer	8.68e-06	6.73e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—MYC—lung cancer	8.64e-06	6.7e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PIK3CD—lung cancer	8.62e-06	6.69e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—AKT1—lung cancer	8.57e-06	6.65e-05	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—PIK3CA—lung cancer	8.54e-06	6.62e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—EGFR—lung cancer	8.45e-06	6.55e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—KRAS—lung cancer	8.44e-06	6.55e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CXCL8—lung cancer	8.39e-06	6.51e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—EP300—lung cancer	8.38e-06	6.5e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—PIK3CA—lung cancer	8.36e-06	6.49e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—HRAS—lung cancer	8.33e-06	6.46e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CYP2E1—lung cancer	8.15e-06	6.32e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—SRC—lung cancer	8.14e-06	6.32e-05	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—AKT1—lung cancer	8.1e-06	6.29e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—TP53—lung cancer	8.09e-06	6.27e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—NQO1—lung cancer	8.06e-06	6.25e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CASP3—lung cancer	8.03e-06	6.23e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IL2—lung cancer	8.02e-06	6.22e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—KRAS—lung cancer	7.98e-06	6.19e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—IL6—lung cancer	7.98e-06	6.19e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—VEGFA—lung cancer	7.93e-06	6.15e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—STAT3—lung cancer	7.85e-06	6.09e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—NRAS—lung cancer	7.84e-06	6.08e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CCND1—lung cancer	7.81e-06	6.06e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—JUN—lung cancer	7.8e-06	6.05e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PTEN—lung cancer	7.77e-06	6.02e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—PIK3CA—lung cancer	7.75e-06	6.02e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—HRAS—lung cancer	7.74e-06	6e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PIK3CB—lung cancer	7.73e-06	6e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MDM2—lung cancer	7.72e-06	5.99e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—RAF1—lung cancer	7.7e-06	5.97e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—APOA1—lung cancer	7.68e-06	5.96e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PTGS2—lung cancer	7.66e-06	5.94e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—ERBB2—lung cancer	7.61e-06	5.91e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MMP9—lung cancer	7.59e-06	5.88e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CDKN1A—lung cancer	7.56e-06	5.86e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PTEN—lung cancer	7.54e-06	5.85e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PIK3CB—lung cancer	7.51e-06	5.83e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MTOR—lung cancer	7.51e-06	5.83e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MAPK3—lung cancer	7.5e-06	5.82e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—EP300—lung cancer	7.41e-06	5.74e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—IL6—lung cancer	7.4e-06	5.74e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—AKT1—lung cancer	7.36e-06	5.71e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—PIK3CA—lung cancer	7.33e-06	5.69e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MYC—lung cancer	7.3e-06	5.66e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—STK11—lung cancer	7.26e-06	5.63e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CXCL8—lung cancer	7.22e-06	5.6e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—EP300—lung cancer	7.19e-06	5.58e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—HRAS—lung cancer	7.17e-06	5.57e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—EGFR—lung cancer	7.14e-06	5.54e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—TP53—lung cancer	7.09e-06	5.5e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PIK3CG—lung cancer	7.01e-06	5.44e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—SRC—lung cancer	6.99e-06	5.43e-05	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—AKT1—lung cancer	6.98e-06	5.41e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CASP3—lung cancer	6.91e-06	5.36e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IL2—lung cancer	6.9e-06	5.35e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—IL6—lung cancer	6.87e-06	5.33e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—AKT1—lung cancer	6.83e-06	5.3e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—VEGFA—lung cancer	6.81e-06	5.28e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—HRAS—lung cancer	6.78e-06	5.26e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—STAT3—lung cancer	6.75e-06	5.23e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—KRAS—lung cancer	6.74e-06	5.23e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—NRAS—lung cancer	6.73e-06	5.22e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CCND1—lung cancer	6.73e-06	5.22e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GSTP1—lung cancer	6.72e-06	5.21e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—JUN—lung cancer	6.71e-06	5.21e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PTEN—lung cancer	6.68e-06	5.18e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—POMC—lung cancer	6.68e-06	5.18e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CAT—lung cancer	6.54e-06	5.07e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MMP9—lung cancer	6.53e-06	5.07e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CDKN1A—lung cancer	6.51e-06	5.05e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CREBBP—lung cancer	6.5e-06	5.04e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PTEN—lung cancer	6.49e-06	5.04e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—IL6—lung cancer	6.49e-06	5.04e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MAPK3—lung cancer	6.44e-06	5e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—EP300—lung cancer	6.37e-06	4.94e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ABCB1—lung cancer	6.36e-06	4.93e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—AKT1—lung cancer	6.33e-06	4.91e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MYC—lung cancer	6.27e-06	4.86e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—TYMS—lung cancer	6.25e-06	4.85e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PIK3CA—lung cancer	6.2e-06	4.81e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—EP300—lung cancer	6.19e-06	4.8e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GSTM1—lung cancer	6.17e-06	4.79e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PIK3CD—lung cancer	6.16e-06	4.78e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—EGFR—lung cancer	6.13e-06	4.76e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—ALB—lung cancer	6.09e-06	4.72e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—SRC—lung cancer	6.02e-06	4.67e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—TP53—lung cancer	5.99e-06	4.65e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—AKT1—lung cancer	5.99e-06	4.65e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—VEGFA—lung cancer	5.87e-06	4.55e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CYP1A1—lung cancer	5.85e-06	4.54e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—STAT3—lung cancer	5.81e-06	4.5e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ERCC2—lung cancer	5.81e-06	4.5e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—NRAS—lung cancer	5.79e-06	4.49e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—KRAS—lung cancer	5.79e-06	4.49e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—HRAS—lung cancer	5.73e-06	4.45e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MAPK3—lung cancer	5.55e-06	4.3e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—IL6—lung cancer	5.49e-06	4.26e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PIK3CA—lung cancer	5.48e-06	4.25e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MYC—lung cancer	5.4e-06	4.19e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PIK3CB—lung cancer	5.37e-06	4.17e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PTGS2—lung cancer	5.32e-06	4.13e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PIK3CA—lung cancer	5.32e-06	4.13e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—EGFR—lung cancer	5.28e-06	4.09e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—TP53—lung cancer	5.15e-06	3.99e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—AKT1—lung cancer	5.06e-06	3.93e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—APOA1—lung cancer	5.02e-06	3.9e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—KRAS—lung cancer	4.99e-06	3.87e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—HRAS—lung cancer	4.92e-06	3.82e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PIK3CA—lung cancer	4.71e-06	3.66e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IL6—lung cancer	4.71e-06	3.65e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PTEN—lung cancer	4.64e-06	3.6e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PIK3CG—lung cancer	4.58e-06	3.56e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PIK3CA—lung cancer	4.58e-06	3.55e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—AKT1—lung cancer	4.48e-06	3.47e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TP53—lung cancer	4.43e-06	3.44e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—EP300—lung cancer	4.43e-06	3.44e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—POMC—lung cancer	4.36e-06	3.39e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—AKT1—lung cancer	4.35e-06	3.37e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CREBBP—lung cancer	4.25e-06	3.3e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—HRAS—lung cancer	4.24e-06	3.29e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IL6—lung cancer	4.06e-06	3.15e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PIK3CD—lung cancer	4.03e-06	3.13e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ALB—lung cancer	3.98e-06	3.09e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—AKT1—lung cancer	3.85e-06	2.99e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—AKT1—lung cancer	3.74e-06	2.9e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PIK3CB—lung cancer	3.51e-06	2.73e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PTGS2—lung cancer	3.48e-06	2.7e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PIK3CA—lung cancer	3.28e-06	2.54e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PTEN—lung cancer	3.04e-06	2.35e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—EP300—lung cancer	2.9e-06	2.25e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—AKT1—lung cancer	2.68e-06	2.08e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PIK3CA—lung cancer	2.14e-06	1.66e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—AKT1—lung cancer	1.75e-06	1.36e-05	CbGpPWpGaD
